Increasing the Incidence and Influence of Systematic Reviews on Health Policy and Practice

Affiliations

¹ Iain Chalmers is a co-founder of the Cochrane Collaboration ( www.cochrane.org ) and the James Lind Initiative, Oxford, UK. Daniel Fox is president emeritus of the Milbank Memorial Fund, New York, NY.

Editorial

Iain Chalmers et al. Am J Public Health. 2016 Jan.

. 2016 Jan;106(1):11-3.

doi: 10.2105/AJPH.2015.302915. Epub 2015 Nov 12.

¹ Iain Chalmers is a co-founder of the Cochrane Collaboration ( www.cochrane.org ) and the James Lind Initiative, Oxford, UK. Daniel Fox is president emeritus of the Milbank Memorial Fund, New York, NY.

No abstract available

Figures

1. Clarke M, Hopewell S. Many reports of randomized trials still don’t begin or end with a systematic review of the relevant evidence. J Bahrain Med Assoc. 2013;2:145–148.
1. Page MJ, Shamseer L, Altman DG, Moher D. Epidemiology and reporting characteristics of systematic reviews: 2014 update. Paper presented at: REWARD/EQUATOR Conference; September 28–30, 2015; Edinburgh, UK.
1. Macleod MR, Michie S, Roberts I et al. Biomedical research: increasing value, reducing waste. Lancet. 2014;383(9912):101–104. - PubMed
1. Fox D. The Convergence of Science and Governance: Research, Health Policy and American States. Berkeley, CA: University of California Press; 2010.
1. Vogel JP, Oxman AD, Glenton C et al. Policymakers’ and other stakeholders’ perceptions of key considerations for health system decisions and the presentation of evidence to inform those considerations: an international survey. Health Res Policy Syst. 2013;11:19. - PMC - PubMed